Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.670
+0.210 (8.54%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Xenetic Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
46541718
Upgrade
Market Cap Growth
15.76%15.76%22.93%-74.96%-3.19%115.27%
Upgrade
Enterprise Value
-2-1-4-10-211
Upgrade
Last Close Price
2.673.993.452.8512.9020.40
Upgrade
PS Ratio
1.652.462.092.5314.8840.83
Upgrade
PB Ratio
0.691.020.540.320.941.46
Upgrade
P/TBV Ratio
1.021.020.540.320.941.46
Upgrade
EV/Sales Ratio
----24.69
Upgrade
Debt / Equity Ratio
----0.000.01
Upgrade
Asset Turnover
0.290.290.200.100.070.03
Upgrade
Quick Ratio
6.906.9011.1012.2012.8412.30
Upgrade
Current Ratio
7.377.3711.8412.7213.1813.20
Upgrade
Return on Equity (ROE)
-50.12%-50.12%-35.27%-40.90%-36.88%-74.03%
Upgrade
Return on Assets (ROA)
-30.02%-30.02%-22.29%-24.32%-21.77%-16.90%
Upgrade
Return on Capital (ROIC)
-33.26%-33.26%-24.08%-26.19%-23.40%-19.90%
Upgrade
Earnings Yield
-96.18%-64.36%-77.78%-151.53%-32.69%-61.06%
Upgrade
FCF Yield
-68.43%-45.79%-77.40%-107.47%-27.43%-23.92%
Upgrade
Buyback Yield / Dilution
-0.86%-0.86%-7.44%-38.38%-60.81%-124.10%
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q